Screening for Helicobacter pylori infection
This test will be obsoleted effective March 1st in effort to conform to current H pylori testing guidelines and to improve patient management. Both the American Gastroenterological Associationg and the American College of Gastroenterology recommend that serologic testing for H pylori be avoided as a means diagnosis of active H pylori infection due to the following limitations:
-poor positive predictive value (PPV)
-poor performance characteristics of these assays compared to alternative tests (MISC Mayo Codes UBT & HPSA)
-serologic testing cannot be used to distinguish active from past infection or to document eradication of the organism following successful treatment
-lack of reimbursement from an increasing number of insurance providers
To minimize improper diagnosis and unnecessary treatment regimens, providers are strongly encouranged to amend their testing strategies by replacing serologic evaluation of patients with suspected H pylori infection, with either the urea breath test (UBT) or stool antigen Test (HPSA).